Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 1
2022 2
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma.
Seiden EE, Richardson SM, Everitt LA, Knafler GJ, Walker AL, Whiteside VA, Pillutla D, Ramnath S, Kinsella GP, Wilburn PA, Buschbach JD, Gandhi DA, Saadatzadeh MR, Wurtz LD, Getty PJ, Padgett SL, Gamblin RM, Childress MO, Fulkerson CM, Capitano ML, Pollok KE, Collier CD, Greenfield EM. Seiden EE, et al. Cancer Res Commun. 2025 Oct 1;5(10):1821-1838. doi: 10.1158/2767-9764.CRC-25-0121. Cancer Res Commun. 2025. PMID: 40952917 Free PMC article.
Therapeutic Targeting of BET Proteins in Sarcoma.
Riyahi N, Malko R, Shannon HE, Jackson KW, Justice RE, Kreklau K, Saadatzadeh MR, Pollok KE, Pandya PH. Riyahi N, et al. Mol Cancer Ther. 2025 Sep 2;24(9):1320-1330. doi: 10.1158/1535-7163.MCT-24-1027. Mol Cancer Ther. 2025. PMID: 40138251 Free PMC article. Review.
The Role of MDM2 in Promoting Genome Stability versus Instability.
Saadatzadeh MR, Elmi AN, Pandya PH, Bijangi-Vishehsaraei K, Ding J, Stamatkin CW, Cohen-Gadol AA, Pollok KE. Saadatzadeh MR, et al. Int J Mol Sci. 2017 Oct 23;18(10):2216. doi: 10.3390/ijms18102216. Int J Mol Sci. 2017. PMID: 29065514 Free PMC article. Review.
The well-known auto-regulatory loop between p53-MDM2 provides an additional layer of control as the cell either repairs DNA damage and survives (i.e., MDM2 re-engages with p53), or undergoes cell death (i.e., MDM2 does not re-engage p53). ...
The well-known auto-regulatory loop between p53-MDM2 provides an additional layer of control as the cell either repairs DNA damage and survi …
Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma.
Barghi F, Saadatzadeh MR, Dobrota EA, Shannon HE, Bailey BJ, Young C, Malko R, Justice R, Riyahi N, Davis C, Bijangi-Vishehsaraei K, Kreklau K, Stevens LK, Koenig J, Sulayman S, Liu S, Wan J, Trowbridge MA, Coy K, Kennedy FM, Sinn AL, Just M, Jackson KW, Sandusky G, Wurtz LD, Collier CD, Mitchell D, Seiden EE, Greenfield EM, Doud E, Mosley A, Angus SP, Ferguson MJ, Pandya PH, Pollok KE. Barghi F, et al. Neoplasia. 2026 Feb;72:101266. doi: 10.1016/j.neo.2025.101266. Epub 2026 Jan 15. Neoplasia. 2026. PMID: 41544376 Free PMC article.
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.
Pandya PH, Jannu AJ, Bijangi-Vishehsaraei K, Dobrota E, Bailey BJ, Barghi F, Shannon HE, Riyahi N, Damayanti NP, Young C, Malko R, Justice R, Albright E, Sandusky GE, Wurtz LD, Collier CD, Marshall MS, Gallagher RI, Wulfkuhle JD, Petricoin EF, Coy K, Trowbridge M, Sinn AL, Renbarger JL, Ferguson MJ, Huang K, Zhang J, Saadatzadeh MR, Pollok KE. Pandya PH, et al. Cancers (Basel). 2022 Dec 30;15(1):259. doi: 10.3390/cancers15010259. Cancers (Basel). 2022. PMID: 36612255 Free PMC article.
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.
Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K. Safa AR, et al. Genes Dis. 2015 Jun;2(2):152-163. doi: 10.1016/j.gendis.2015.02.001. Genes Dis. 2015. PMID: 26137500 Free PMC article.
CSCs display the malignant phenotype, self-renewal ability, altered genomic stability, specific epigenetic signature, and most of the time can be phenotyped by cell surface markers (e.g., CD133, CD24, and CD44). Numerous studies support the concept that non-stem cancer cel …
CSCs display the malignant phenotype, self-renewal ability, altered genomic stability, specific epigenetic signature, and most of the time c …